Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT04800315

Public ClinicalTrials.gov record NCT04800315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 1:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Global, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Cendakimab (CC-93538) in Adult Subjects With Moderate to Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

Study identification

NCT ID
NCT04800315
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celgene
Industry
Enrollment
221 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 14, 2021 (Actual)
Primary completion
Jul 20, 2022 (Actual)
Completion
Nov 9, 2022 (Actual)
Last update posted
Jan 3, 2024

2021 – 2022

United States locations

U.S. sites
62
U.S. states
21
U.S. cities
31
Facility City State ZIP Site status
Clinical Research Center of Alabama Birmingham Alabama 35209 —
Local Institution - 119 Birmingham Alabama 35209 —
Cahaba Dermatology Birmingham Alabama 35244 —
Local Institution - 114 Birmingham Alabama 35244 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913-6440 —
Local Institution - 129 Hot Springs Arkansas 71913-6440 —
First OC Dermatology Fountain Valley California 92708 —
Local Institution - 105 Fountain Valley California 92708 —
George Washington University School of Medicine and Health Sciences Washington D.C. District of Columbia 20037-3201 —
Local Institution - 128 Washington D.C. District of Columbia 20037-3201 —
Total Vein and Skin, LLC Boynton Beach Florida 33437 —
Local Institution - 106 Delray Beach Florida 33484-6500 —
Palm Beach Dermatology Group Delray Beach Florida 33484-6500 —
GCP Global Clinical Professionals St. Petersburg Florida 33702 —
Local Institution - 135 St. Petersburg Florida 33702 —
ForCare Clinical Research Tampa Florida 33624-2038 —
Local Institution - 101 Tampa Florida 33624-2038 —
Local Institution - 103 West Palm Beach Florida 33401-3430 —
Metabolic Research Institute Inc West Palm Beach Florida 33401-3430 —
Aeroallergy Research Labs of Savannah Savannah Georgia 31406-2668 —
Local Institution - 134 Savannah Georgia 31406-2668 —
Local Institution - 108 Springfield Illinois 62702-5115 —
Sneeze Wheeze and Itch Associates LLC Springfield Illinois 62702-5115 —
DS Research Clarksville Indiana 47129-2201 —
Local Institution - 115 Clarksville Indiana 47129-2201 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256 —
Local Institution - 110 Indianapolis Indiana 46256 —
Local Institution - 107 West Lafayette Indiana 47906-1569 —
Randall Dermatology West Lafayette Indiana 47906-1569 —
Local Institution - 138 Westfield Indiana 46074 —
Randall Dermatology - Westfield Campus Westfield Indiana 46074 —
Kansas City Dermatology P.A. Overland Park Kansas 66215-2377 —
Local Institution - 116 Overland Park Kansas 66215-2377 —
DS Research Louisville Kentucky 40241 —
Local Institution - 117 Louisville Kentucky 40241 —
DermAssociates Silver Spring Maryland 20902-5006 —
Local Institution - 125 Silver Spring Maryland 20902-5006 —
Local Institution - 133 Clarkston Michigan 48346 —
Skin Research Clarkston/Clarkston Dermatology Clarkston Michigan 48346 —
Local Institution - 137 Omaha Nebraska 68144 —
Skin Specialists PC Omaha Nebraska 68144 —
JDR Dermatology Research, LLC Las Vegas Nevada 89148 —
Local Institution - 121 Las Vegas Nevada 89148 —
Local Institution - 112 Hackensack New Jersey 07601-1974 —
Skin Laser and Surgery Specialists of New York and New Jersey LLC Hackensack New Jersey 07601-1974 —
Icahn School of Medicine at Mount Sinai Great Neck New York 11021-5506 —
Local Institution - 130 Great Neck New York 11021-5506 —
Local Institution - 126 New York New York 10075 —
Sadick Research Group New York New York 10075 —
Central Sooner Research Norman Oklahoma 73069-6301 —
Local Institution - 111 Norman Oklahoma 73069-6301 —
Local Institution - 127 Tulsa Oklahoma 74136-8303 —
Vital Prospects Clinical Research Institute PC - CRN - PPDS Tulsa Oklahoma 74136-8303 —
Local Institution - 109 Portland Oregon 97223 —
Oregon Medical Research Center, P.C. Portland Oregon 97223 —
Clinical Partners, LLC Johnston Rhode Island 02919 —
Local Institution - 123 Johnston Rhode Island 02919 —
International Clinical Research Murfreesboro Tennessee 37130 —
Local Institution - 100 Murfreesboro Tennessee 37130 —
Clinical Research Partners LLC Henrico Virginia 23233-1487 —
Local Institution - 104 Richmond Virginia 23233-1436 —
West End Dermatology Associates Richmond Virginia 23233-1436 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04800315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2024 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04800315 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →